ANDOVER,
Mass., Dec. 18, 2023 /PRNewswire/ -- TransMedics
Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology
company that is transforming organ transplant therapy for patients
with end-stage lung, heart, and liver failure, today announced that
members of the management team will present at the upcoming
42nd Annual J.P. Morgan Healthcare Conference. The
presentation will take place on Monday,
January 8, 2024, at 3:00 p.m. Pacific
Standard Time / 6:00 p.m. Eastern
Standard Time.
Event: 42nd Annual J.P. Morgan Healthcare
Conference
Date: Monday, January 8,
2024
Time: 3:00 p.m. PST
A live and archived webcast of the presentation will be
available on the "Investors" section of the TransMedics website at
https://investors.transmedics.com/.
About TransMedics Group, Inc.
TransMedics is the
world's leader in portable extracorporeal warm perfusion and
assessment of donor organs for transplantation. Headquartered in
Andover, Massachusetts, the
company was founded to address the unmet need for more and better
organs for transplantation and has developed technologies to
preserve organ quality, assess organ viability prior to transplant,
and potentially increase the utilization of donor organs for the
treatment of end-stage heart, lung, and liver failure.
Investor Contact:
Brian
Johnston
332-895-3222
Investors@transmedics.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/transmedics-to-participate-in-the-42nd-annual-jp-morgan-healthcare-conference-302018201.html
SOURCE TransMedics Group, Inc.